Ark Therapeuticcs Ark Therapeutics is a innovative viral vaccine service company.  Based in Kuopio, Finland Ark provides viral process development and cGMP manufacturing/Fill Finish for third party clients at a variety of  stages of therapeutic development.  The capability includes:   - 3 self-contained manufacturing suites, all able to accommodate products requiring BSL-2 (such as viruses) - Research/Development expertise from naked DNA to live viral products - Our service capability in development sequence can be selected at different starting points, whether it’s a new concept or process scale-up. - Process development, cGMP manufacture of bulk drug substance, fill and finish and release testing - Potential access to Ark's unique platforms in adenoviral and lentiviral vector production - Opportunity to partner with Ark's expertise through all or any phase of product development, from research, through clinical trials and into commercialisation